Multi-omics technology platform for precision prediction and diagnosis of diabetes with cardiovascular disease. Enables genetic risk stratification and clinical decision support for high-risk populations.
Manufactured by
Shenzhen Create Medical Technology Co., Ltd.
China
Shenzhen Create Medical Technology Co., Ltd. manufactures breath diagnostic devices for detecting conditions including H. pylori infection (13C/14C breath tests), gastrointestinal disorders (hydrogen/methane analyzers), airway inflammation (NO analyzers), and halitosis (VSC analyzers). The company also produces non-invasive diabetes screening equipment using AGE detection technology and AI-assisted medical examination systems. Products are exported to over 20 countries.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Mediwhale Inc.
South Korea · 1 relevant product
Verge HealthTech Fund
Singapore · 4 relevant products
Beijing sinotech&wellcare technology and development Co.,Ltd
China · 4 relevant products
46 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 68 closest product alternatives
Mediwhale Inc. · South Korea
Integrated AI platform for early detection and personalized risk assessment of cardiometabolic diseases through retinal imaging analysis. Designed for seamless integration into hospital and clinic information systems globally.
Verge HealthTech Fund · Singapore
Comprehensive digital disease management platform for diabetes care serving East Asian populations. The system integrates patient monitoring, data analytics, and clinical decision support for diabetes management.
Beijing sinotech&wellcare technology and development Co.,Ltd · China
A SaaS-based platform for medical institutions managing chronic diseases including diabetes, coronary heart disease, and stroke across diagnosis, treatment, and rehabilitation. Includes real-time glucose alerts, AI clinical decision support, multi-terminal coordination, and remote consultation capabilities with level 3 data security compliance.
65 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products